Prof. Dr. Lothar Häberle

Department of Obstetrics and Gynaecology Medizinische Fakultät

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients (2020) Hack C, Häberle L, Brucker SY, Janni W, Volz B, Löhberg C, Hartkopf AD, et al. Journal article RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women (2020) Wunderle M, Rübner M, Häberle L, Schwenke E, Hack C, Bayer CM, Koch M, et al. Journal article Impact - Implementing Patients' Competence in Oral Breast Cancer Therapy - A Randomized, Controlled Study of Standardized Patient Coaching Versus Patient Management According to Local Practice for Patients with HR Positive HER2 Negative Metastatic Breast Cancer Treated with Abemaciclib (2020) Welslau M, Nabieva N, Decker T, Belleville E, Knapp O, Häberle L, Fasching P, Tesch H Conference contribution Genetic variants in the glucocorticoid pathway genes and birth weight (2020) Schneider M, Hübner T, Pretscher J, Goecke TW, Schwitulla J, Häberle L, Kornhuber J, et al. Journal article Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine (2020) Hack C, Wasner S, Meyer J, Häberle L, Jud S, Hein A, Wunderle M, et al. Journal article Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the Guidelines (2020) Lux MP, Wasner S, Meyer J, Häberle L, Hack C, Jud S, Hein A, et al. Journal article Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients (2020) Erber R, Rübner M, Davenport S, Hauke S, Beckmann M, Hartmann A, Häberle L, et al. Journal article Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2020) Wunderle M, Häberle L, Hein A, Jud S, Lux MP, Hack C, Emons J, et al. Journal article Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center (2020) Löhberg C, Meyer J, Häberle L, Hack C, Jud S, Hein A, Wunderle M, et al. Journal article Prediction and clinical utility of a contralateral breast cancer risk model (2019) Giardiello D, Steyerberg EW, Hauptmann M, Adank MA, Akdeniz D, Blomqvist C, Bojesen SE, et al. Journal article